|
Market Closed -
London S.E.
11:35:15 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.1400 GBX | -3.45% |
|
-9.68% | -58.21% |
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
| Market Cap | 1.91M 2.59M 2.23M 2.1M 3.58M 244M 3.61M 24.88M 9.65M 125M 9.71M 9.5M 410M | P/E 2024 |
-0.53x | P/E 2025 | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 1.12M 1.52M 1.31M 1.23M 2.1M 143M 2.12M 14.61M 5.67M 73.33M 5.7M 5.58M 241M | EV / Sales 2024 |
27,264,249x | EV / Sales 2025 | 54,121,446x |
| Free-Float |
91.05% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.45% | ||
| 1 week | -9.68% | ||
| Current month | -9.68% | ||
| 1 month | -6.67% | ||
| 3 months | -26.32% | ||
| 6 months | -58.21% | ||
| Current year | -58.21% |
| 1 week | 0.13 |  | 0.16 |
| 1 month | 0.13 | | 0.18 |
| Current year | 0.13 | | 0.48 |
| 1 year | 0.13 | | 0.85 |
| 3 years | 0.13 | | 15 |
| 5 years | 0.13 | | 65 |
| 10 years | 0.13 | | 1,436.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Eccleston
CEO | Chief Executive Officer | 55 | 2024-08-11 |
Gerald Desler
DFI | Director of Finance/CFO | 81 | - |
Michelle Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerald Desler
BRD | Director/Board Member | 81 | 2006-08-31 |
| Chairman | 60 | 2024-07-24 | |
Mark Eccleston
BRD | Director/Board Member | 55 | 2024-08-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/4/26 | Buy | Chief Executive Officer | 1,000,000 | 0.1346% | ||
| 10/18/22 | Free | Director | 75,000 | 0.0832% | ||
| 10/18/22 | Free | Director | 75,000 | 0.0832% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.45% | -9.68% | -80.69% | -97.76% | 2.59M | |
| +1.03% | -3.11% | +39.80% | +94.60% | 68.21B | |
| +1.62% | +0.33% | +48.61% | +89.64% | 64.25B | |
| +1.46% | -0.72% | -15.00% | +368.34% | 26.54B | |
| +1.26% | -8.36% | +2.52% | -15.45% | 25.61B | |
| +1.30% | +0.74% | +31.66% | -18.33% | 19.88B | |
| -0.38% | -12.42% | +224.86% | +373.18% | 17.13B | |
| +0.65% | -5.83% | +1.44% | +544.44% | 14.93B | |
| +1.45% | +3.05% | +55.49% | +159.59% | 14.1B | |
| +0.68% | +0.77% | +24.51% | +194.32% | 12.45B | |
| Average | +0.55% | -4.02% | +33.32% | +169.26% | 26.31B | |
| Weighted average by Cap. | +1.15% | -3.01% | +42.17% | +153.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.05 0.07 0.06 0.05 0.09 6.35 0.09 0.65 0.25 3.25 0.25 0.25 10.67 | 0.03 0.04 0.04 0.03 0.06 4 0.06 0.41 0.16 2.05 0.16 0.16 6.72 |
| Net income | -1.92M -2.59M -2.23M -2.1M -3.58M -244M -3.61M -24.89M -9.66M -125M -9.72M -9.5M -410M | -2.23M -3.01M -2.6M -2.45M -4.17M -285M -4.2M -29M -11.26M -146M -11.32M -11.07M -478M |
| Net Debt | -1.54M -2.09M -1.8M -1.69M -2.89M -197M -2.91M -20.06M -7.79M -101M -7.83M -7.66M -331M | -790K -1.07M -921K -867K -1.48M -101M -1.49M -10.27M -3.98M -51.54M -4.01M -3.92M -169M |
Employees
11
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | GBX 0.1400 | -3.45% | 2,786,069 |
| 26-09-01 | GBX 0.1450 | -6.45% | 16,976,047 |
| 26-08-28 | GBX 0.1550 | 0.00% | 1,623,658 |
| 26-08-27 | GBX 0.1550 | 0.00% | 729,861 |
| 26-08-26 | GBX 0.1550 | 0.00% | 14,692 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VAL Stock
Select your edition
All financial news and data tailored to specific country editions
